医药导报
醫藥導報
의약도보
HERALD OF MEDICINE
2014年
9期
1160-1164
,共5页
戚翔%梁治%卢怀海%薄立军%高璐超%徐雪
慼翔%樑治%盧懷海%薄立軍%高璐超%徐雪
척상%량치%로부해%박립군%고로초%서설
舒芬太尼%右美托咪定%儿科学%麻醉诱导%麻醉趋势指数
舒芬太尼%右美託咪定%兒科學%痳醉誘導%痳醉趨勢指數
서분태니%우미탁미정%인과학%마취유도%마취추세지수
Sufentanil%Dexmedetomidine%Pediatrics%Anesthesia induction%Narcotrend index
目的:观察不同剂量舒芬太尼联合右美托咪定输注对小儿全身麻醉诱导期血流动力学及麻醉趋势指数(NI)的影响。方法下腹部手术患儿45例,随机分为3组:舒芬太尼0.1μg·kg-1+右美托咪定组(S1组)、舒芬太尼0.2μg·kg-1+右美托咪定组(S2组)、舒芬太尼0.3μg·kg-1+右美托咪定组(S3组),每组15例。各组达用药时点后直视气管插管,分别于基础值(t0),右美托咪定0.5μg·kg-1·h-1静脉滴注5 min时(t1)、静脉滴注舒芬太尼3 min时(t2)、插管即刻( t3)、插管后1 min( t4)、5 min( t5)时观察血压、心率、末梢灌注指数( PI)、NI,记录各组阿托品及丙泊酚的应用率,观察苏醒时间及不良反应。结果各组t1、t2时点血流动力学指标和NI 值均显著低于t0时的基础值,PI显著高于t0时的基础值;t3、t4、t5时点S1组上述指标与t0比较差异有统计学意义,且与S2、S3组相比差异有统计学意义;S2、S3组无显著变化;S1组应用丙泊酚6例、手术后躁动4例,较S2、S3组明显增多。 S3组应用阿托品3例。结论0.2μg·kg-1舒芬太尼联合右美托咪定诱导插管用于小儿麻醉,血流动力学稳定,不良反应少。
目的:觀察不同劑量舒芬太尼聯閤右美託咪定輸註對小兒全身痳醉誘導期血流動力學及痳醉趨勢指數(NI)的影響。方法下腹部手術患兒45例,隨機分為3組:舒芬太尼0.1μg·kg-1+右美託咪定組(S1組)、舒芬太尼0.2μg·kg-1+右美託咪定組(S2組)、舒芬太尼0.3μg·kg-1+右美託咪定組(S3組),每組15例。各組達用藥時點後直視氣管插管,分彆于基礎值(t0),右美託咪定0.5μg·kg-1·h-1靜脈滴註5 min時(t1)、靜脈滴註舒芬太尼3 min時(t2)、插管即刻( t3)、插管後1 min( t4)、5 min( t5)時觀察血壓、心率、末梢灌註指數( PI)、NI,記錄各組阿託品及丙泊酚的應用率,觀察囌醒時間及不良反應。結果各組t1、t2時點血流動力學指標和NI 值均顯著低于t0時的基礎值,PI顯著高于t0時的基礎值;t3、t4、t5時點S1組上述指標與t0比較差異有統計學意義,且與S2、S3組相比差異有統計學意義;S2、S3組無顯著變化;S1組應用丙泊酚6例、手術後躁動4例,較S2、S3組明顯增多。 S3組應用阿託品3例。結論0.2μg·kg-1舒芬太尼聯閤右美託咪定誘導插管用于小兒痳醉,血流動力學穩定,不良反應少。
목적:관찰불동제량서분태니연합우미탁미정수주대소인전신마취유도기혈류동역학급마취추세지수(NI)적영향。방법하복부수술환인45례,수궤분위3조:서분태니0.1μg·kg-1+우미탁미정조(S1조)、서분태니0.2μg·kg-1+우미탁미정조(S2조)、서분태니0.3μg·kg-1+우미탁미정조(S3조),매조15례。각조체용약시점후직시기관삽관,분별우기출치(t0),우미탁미정0.5μg·kg-1·h-1정맥적주5 min시(t1)、정맥적주서분태니3 min시(t2)、삽관즉각( t3)、삽관후1 min( t4)、5 min( t5)시관찰혈압、심솔、말소관주지수( PI)、NI,기록각조아탁품급병박분적응용솔,관찰소성시간급불량반응。결과각조t1、t2시점혈류동역학지표화NI 치균현저저우t0시적기출치,PI현저고우t0시적기출치;t3、t4、t5시점S1조상술지표여t0비교차이유통계학의의,차여S2、S3조상비차이유통계학의의;S2、S3조무현저변화;S1조응용병박분6례、수술후조동4례,교S2、S3조명현증다。 S3조응용아탁품3례。결론0.2μg·kg-1서분태니연합우미탁미정유도삽관용우소인마취,혈류동역학은정,불량반응소。
Objective To investigate the effect of different doses of sufentanil combined with dexmedetomidine ( DEX) on hemodynamic and Narcotrend index ( NI) during pediatric anesthesia induction. Methods A total of 45 children with lower abdominal surgery were randomly divided into three groups evenly: sufentanil 0. 1 μg·kg-1+ DEX (S1 group),sufentanil 0. 2 μg·kg-1+DEX (S2 group),and sufentanil 0. 3μg·kg-1+DEX (S3 group). Patients in each group began with intubation at the peak point of administration. Blood pressure,heart rate,perfusion index (PI) and NI were detected at the baseline (t0), delivering DEX 0.5 μg·kg-1·h-1 and sufentanil intravenously for 5 min (t1),delivering sufentanil for 3 min (t2),time of intubation ( t3 ) ,1 min ( t4 ) ,and 5 min ( t5 ) after intubation. The application rate of atropine and propofol was recorded. Patient recovery time and adverse reactions were observed. Results Compared with basicline value at t0 time point, hemodynamic parameters and NI were decreased at t1 and t2 ,while PI was increased in both groups. At t3 ,t4 ,and t5 ,all of the indicators in S1 group were significantly different from those at t0 ,and also significantly different from those in S2 and S3 group. Six patients were treated with propofol in S1 group and four presented with agitation after operation,more than S2 and S3 groups. Three patients were treatment with atropine in S3 group. Conclusion Sufentanil (0. 2 μg·kg-1 ) combined with dexmedetomidine can be used to induce intubation for pediatric anesthesia with stable hemodynamic profile and low incidence of adverse effects.